Live Robotaxi Rollout2,201Tesla
robotaxis
  • Bay Area, CA1,655 Model YsSafety driver
  • Texas546 (126 Cybercab · 420 Model Y)Driverless
  • Miami, FLModel Y fleet · count not disclosedDriverless
  • Orlando, FLModel Y fleet · count not disclosedDriverless
  • Tampa, FLModel Y fleet · count not disclosedDriverless
  • Las Vegas, NVPermit for up to 5,000 robotaxisApproved
  • Phoenix, AZLaunch preparations under wayComing soon

Neuralink Moves to High-Volume Implant Production in 2026

Neuralink is scaling from one-off surgeries to high-volume manufacturing of its N1 brain implant, with a near-automated procedure and a dozen patients already living with the device.

3 min read
Neuralink Moves to High-Volume Implant Production in 2026

FREMONT, Calif. — Neuralink is making the leap that separates a research project from a real product. The company says it will begin high-volume production of its N1 brain-computer interface this year while moving to a surgical procedure that is almost entirely automated, a combination that could take the implant from a handful of pioneering patients to a broadly available medical device.

From a Dozen Pioneers to Many More

The push builds on a track record that is already remarkable. Neuralink has implanted its device in roughly a dozen patients with severe paralysis, beginning with Noland Arbaugh, who received his implant in early 2025 and has used it to play video games, browse the web and control a computer with his thoughts alone. More recent participants have gone further still, with one patient sending his first message straight from his brain and others steering devices they could never have operated by hand.

The N1 implant replaces a small disc of skull and reads activity through 1,024 electrodes spread across 64 ultra-thin threads. Where early surgeries required removing the dura, the tough membrane around the brain, Musk says the threads will now pass through it directly, a refinement he called a genuine breakthrough for speed and safety.

Building the Factory and the Robot Surgeon

Scaling means two things happening at once: making far more implants, and making the operation fast and repeatable. Neuralink's R1 surgical robot already inserts a single thread in about 1.5 seconds and reaches depths that cover the overwhelming majority of human brain anatomy, laying the groundwork for a procedure that can be performed consistently at many hospitals rather than a single specialized center.

Neuralink Moves to High-Volume Implant Production in 2026 — additional image

That industrial ambition is matched by investor confidence. The company raised a $650 million round to expand patient access, and its shares have since traded briskly on the secondary market, with the valuation climbing toward $42 billion as demand for exposure to the technology grows.

A Clear Regulatory Runway

Regulators have signaled they want this to move quickly too. Neuralink has secured an FDA Breakthrough Device Designation aimed at speech restoration, a pathway meant to accelerate review for devices that address serious unmet needs. Combined with the automated-surgery goal, that designation points toward a future in which restoring communication and movement is a scheduled procedure rather than an experiment. As Musk framed the year ahead in comments highlighted by Fierce Biotech, Neuralink is shifting into high gear.

If the company hits even part of its 2026 targets, the story stops being about whether a brain implant can work and starts being about how many people it can reach. For patients waiting to reclaim speech, movement and independence, that shift cannot come soon enough.